Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVL vs Propranolol for Secondary Prophylaxis in NCPH
NCT01000779Phase 3Completed
- Sponsor
- Govind Ballabh Pant Hospital
- Start
- Jan 2005
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of propranolol in non-cirrhotic portal hypertension (NCPH) (2 arms), sponsored by Govind Ballabh Pant Hospital. Primary endpoints: Rebleed at 3 months and Death at 3 months. Started Jan 2005; status: completed.
02
Drugs
propranolol
03
Conditions
non-cirrhotic portal hypertension (NCPH)
Beyond the preview
Go deeper on NCT01000779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01000779.